Advances in cancer research. Volume 69 /
This volume of Advances in Cancer Research begins with a "Foundations in Cancer Research" articles by Harold Varmus. He focuses on Andrew Lwoff who influenced a generation of scientists and how Dr. Lwoff's influence on Howard Temlin, in particular, led to the identification of the cau...
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | , |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
San Diego, Calif. ; London :
Academic Press,
�1996.
|
Colección: | Advances in cancer research ;
v. 69 |
Temas: | |
Acceso en línea: | Texto completo Texto completo |
Tabla de Contenidos:
- Front Cover; Advances in Cancer Research, Volume 69; Copyright Page; Contents; Contributors to Volume 69; Chapter 1. Foundations in Cancer Research: The Pastorian: A Legacy of Louis Pasteur; Chapter 2. Cell Cycle Control in Fission Yeast and Mammals: Identification of New Regulatory Mechanisms; I. Introduction; II. Life Cycle of Fission Yeast; Ill. Cell Cycle Start Control of Fission Yeast; IV. Cell Cycle Start Control of Mammals; V. Mitotic Start Control of Fission Yeast; VI. Mitotic Start Control of Mammals; VII. Closing Remarks; References
- Chapter 3. Cytogenetics and Molecular Genetics of Bone and Soft Tissue tumorsI. Introduction; II. Cytogenetic and Major Molecular Genetic Findings; III. Aberrations Shared by Several Tumor Types; IV. Diagnosis and Prognostication Based on Genetic Analysis; References; Chapter 4. Plasminogen Activation on Tumor Cell Surface and Its Involvement in Human Leukemia; I. Introduction; II. Components of Plasminogen Activation; III. Activation of Plasminogen on Cell Surface; IV. Regulators of Plasminogen Activation; V. Internalization of uPA; VI. Plasminogen Activators in Tumors
- VII. Plasminogen Activators in Cell MigrationVIII. Plasminogen Activation and Leukemia; IX. Future Aspects; References; Chapter 5. How tumors Become Angiogenic; I. Introduction; II. Tumor Angiogenesis; III. Development of an Angiogenic Phenotype; IV. Therapeutic Strategies Targeting Tumor Angiogenesis; V. Conclusions; References; Chapter 6. Immunity to Human Papillomavirus-Associated Cervical Neoplasia; I. Introduction; II. Human Papillomaviruses; III. Immunological Recognition of HPV in Cervical Neoplasia; IV. Evasion of Immune Surveillance; V. Prospects for Immune Intervention
- VI. ConclusionsReferences; Chapter 7. Strategies Involved in Developing an Effective Vaccine to EBV-Associated Diseases; I. Introduction; II. Host-Virus Relationships; III. Humoral Response to EBV Infection; IV. CTL Response to EBV Infection; V. Developing a Vaccine for EBV; VI. Vaccines and Immunotherapy for EBV-Associated Diseases; References; Index